Palbociclib 125mg Tablets

* To be consumed as directed by physician.

Palbib 125mg Tablet

Palbociclib Tablets
It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. Palbociclib was the first CDK4/6 inhibitor to be approved in management of Breast cancer.
It is indicated for the management of HR+ve and HER2-ve advanced or metastatic breast cancer
(4.5 Rating)

Note : This Product is NOT FOR SALE IN INDIA

Product Enquiry